in Search   (clear all)


Found 300 results

Showing 1 to 30

BOOKLET 3: NATIONAL PATIENTS’ RIGHTS CHARTER

The Patient rights charter outlines a patents rights and responsibilities with respect to health care. Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be…

Related Tags (New Search): HPCSA

POSITION STATEMENT: TRANSITIONAL ARRANGEMENTS FOR MEDICAL DEVICES (MCC 9.96, JUN 2017)

Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be liable, in any manner whatsoever, for any damages incurred through the use of third-party websites.

Related Tags (New Search): Licencing,   Medical devices,   IVDs,   Importers,   Wholesaler,   Manufacturers

CLASSIFICATION of MEDICAL DEVICES and IVDs: (MCC: July 17)

Classification of Medical Devices and IVDs

Related Tags (New Search): Medical devices,   IVDs,   Classification

NOTIFICATION STUDIES: PHASE IV (MCC, May 17)

Template for the notification with respect to conducting of phase 4 (post-marketing) studies on medicines in South Africa. Circular 6.24

SAFETY-RELATED PACKAGE INSERT NOTIFICATIONS (SR-PINs) - (MCC: Aug 17)

Safety-related Package Insert Notifications (SR PINS) in South Africa.Circular 2.17.

Related Tags (New Search): Allopathic medicines,   Complementary medicines,   Safety,   Adverse Drug Reaction,   SRPINS,   Adverse Drug Event,   Post-marketing

Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances (GN 1589 in GG 40515 of 23 December 2016)

Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances (GN 1589 in GG 40515 of 23 December 2016)

IMSA NHI Policy Brief 12 Impact of Reform on Members vF

IMSA NHI Policy Brief 12 Impact of Reform on Members vF

IMSA NHI Policy Brief 22 Social Solidarity in OECD Countries vF

IMSA NHI Policy Brief 22 Social Solidarity in OECD Countries vF

CAMs Specified Substances 7.06 v2, Jun 2018

COMPLEMENTARY MEDICINES GUIDANCE ON SPECIFIED SUBSTANCES

Related Tags (New Search): Complementary medicines

9.116_SAHPRA_Update_Civitas_Closure_Oct18_v1

SAHPRA Update Civitas Closure

BOOKLET 4: SEEKING PATIENTS’ INFORMED CONSENT: THE ETHICAL CONSIDERATIONS

HPCSA guidelines on seeking patients informed consent. Principles of good practice which all healthcare practitioners are expected to follow when seeking patients informed consent to investigations, treatment screening or research. Please note that this is a third-party website. Juta has…

Related Tags (New Search): HPCSA,   Informed Consent

Exclusion of Certain Medicines from the Operation of the Medicines and Related Substances Act 101 of 1965 (GN 565 in GG 40015 of 25 May 2016)

Exclusion of Certain Medicines from the Operation of the Medicines and Related Substances Act 101 of 1965 (GN 565 in GG 40015 of 25 May 2016)

Related Tags (New Search): S0

Aerosol Manufacturing (MCC: 4.03, Jun 2003)

Specific GMP guidelines on the manufacture of aerosol – based medicines. Circular 4.03

Related Tags (New Search): GMP

Bioavailability and Bioequivalence of Veterinary Medicines (MCC: 3.03, Jan 2004)

Bioavailability and Bioequivalence of Veterinary Medicines. Secular 3.03

Related Tags (New Search): Veterinary medicine

(Showing 1 to 30 of 300 results)